Thesis
VIAVI sells the test, assurance, and optical tools used to validate networks before operators trust them with real traffic. That matters whenever bandwidth, architecture, or mission requirements change faster than the installed base can comfortably absorb. More complex fiber networks, AI-related data-center connectivity, and defense communication systems all create places where test becomes essential instead of optional.
The story is not as clean as some other names in the library, but it is improving. In fiscal second quarter 2026, VIAVI reported revenue of $369.3 million, up 36.4% year over year, with non-GAAP operating margin of 19.3%. Management said strong momentum and demand in the data-center ecosystem and aerospace and defense applications should continue driving growth through calendar 2026. The real question is whether the better end markets become large enough to permanently improve the mix, or whether the stock remains a turnaround-value story with periodic bursts of better demand. If the former, there is more upside than people think. If the latter, it stays a useful but less core name.
VIAVI is clearly seeing stronger demand in better end markets. The real question is whether that better mix is durable enough to make the stock more than a cyclical telecom-tool recovery.
Valuation and financials
The 4Ps
Oleg Khaykin has already improved the business materially, but the market still needs evidence that better end markets can sustainably shape the mix rather than simply lifting a few quarters.
VIAVI's relevance comes from testing and assuring more complex optical and communications environments. That is a useful lane whenever architectures change fast enough that the installed base cannot be trusted without better validation.
The best version of the story is not just more revenue. It is that data-center ecosystem demand and aerospace and defense become a larger, higher-quality part of the company than investors are used to assuming.
Recent results were strong, but VIAVI still has more turnaround flavor than a true bottleneck platform. The confidence band is therefore lower than for the cleanest supercycle names.
Portfolio manager lens
Starting point: VIAVI is a more peripheral but improving way to own network-validation demand.
What is in the stock: stronger data-center ecosystem and aerospace demand, better margins, and the possibility of a cleaner mix.
What can still surprise upside: the better end markets becoming a larger share of the business and sustaining margin quality.
What changes the view: a relapse into ordinary telecom-tool cyclicality or failure of the better mix to become durable.
Trade framing
VIAVI is not a first-line supercycle name, but it can still be useful if the data-center and aerospace mix keeps getting better. The right framing is selective, not maximalist.
The next checkpoints are straightforward: does revenue remain strong after the $369.3 million fiscal second-quarter result, do margins stay healthy, and does management keep emphasizing the same better end markets? If yes, the turnaround-to-better-mix case holds. If not, the stock remains more peripheral to the core library.
What matters now
What matters now is whether better demand in network validation, optical security, and anti-counterfeit programs proves durable enough to overcome the stock's long history as a recovery name. The checkpoints are NSE order quality, OSP mix, and whether margins improve as the better businesses make up more of revenue.
Key questions
VIAVI sells test, assurance, and optical technologies used in communications and other technical markets. The practical point is that it gets paid when systems become hard enough to validate that customers cannot simply rely on legacy tools or guesswork.
That can mean test and measurement for communications networks, optical tools, and applications tied to government or aerospace communications. It is not the cleanest story in the library, but it is clearly exposed to complexity-driven validation demand.
Thesis last reviewed April 2, 2026. Live data updates automatically.